Skip to content

PHARMACIE DUBUISSON: what changed

What changed

PHARMACIE DUBUISSON

BE 0508.493.004
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€86,387
2024 · €80,043+€6,344
Equity
€398,417
2024 · €361,696+€36,721
Cash
€471,832
2024 · €460,843+€10,988
Balance sheet total
€590,452
2024 · €585,015+€5,436

Largest movements

2024 to 2025
Assets
  • Cash +€10,988

    up €10,988 (+2.4%), from €460,843 to €471,832

    mainly Net result for the year (+€86,387) and Depreciation (+€8,695)

Equity and liabilities
  • Reserves +€42,000

    up €42,000 (+12.5%), from €336,000 to €378,000

  • Current portion of long-term debt -€20,000

    down €20,000 (-80.0%), from €25,000 to €5,000

  • Tax, wage and social debts -€8,024

    down €8,024 (-25.9%), from €31,030 to €23,005

    of which Taxes: -€8,166

Income statement
  • Gross operating margin +€7,280

    up €7,280 (+4.6%), from €157,592 to €164,872

  • Taxes +€2,893

    up €2,893 (+9.1%), from €31,661 to €34,554

  • Depreciation -€2,835

    down €2,835 (-24.6%), from €11,530 to €8,695

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €80,043
Gross operating margin +€7,280
Staff costs -€1,272
Depreciation +€2,835
Other operating charges -€37
Financial income -€81
Financial charges +€512
Taxes -€2,893
Result 2025 €86,387
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€88,754
Investment -€3,100
Financing -€74,666
Cash 2024 €460,843
Net result for the year +€86,387
Depreciation +€8,695
Stocks and contracts +€1,259
Receivables within one year -€100
Deferred charges and accrued income -€1,201
Trade debts -€3,188
Tax, wage and social debts -€8,024
Other debts +€5,448
Accrued charges and deferred income -€521
Investment in fixed assets (net) -€3,100
Debts after one year -€5,000
Current portion of long-term debt -€20,000
Contributions, distributions and other -€49,666
Cash 2025 €471,832
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €585,015 €590,452 +€5,436 +0.9%
Fixed assets 21/28 €28,756 €23,162 -€5,595 -19.5%
Tangible fixed assets 22/27 €28,756 €23,162 -€5,595 -19.5%
Furniture and vehicles 24 €25,632 €17,528 -€8,103 -31.6%
Other tangible fixed assets 26 €3,125 €5,633 +€2,509 +80.3%
Current assets 29/58 €556,259 €567,290 +€11,031 +2.0%
Stocks and contracts in progress 3 €46,677 €45,418 -€1,259 -2.7%
Stocks 30/36 €46,677 €45,418 -€1,259 -2.7%
Amounts receivable within one year 40/41 €46,325 €46,425 +€100 +0.2%
Trade receivables 40 €33,770 €43,086 +€9,316 +27.6%
Other amounts receivable 41 €12,555 €3,339 -€9,216 -73.4%
Cash at bank and in hand 54/58 €460,843 €471,832 +€10,988 +2.4%
Deferred charges and accrued income 490/1 €2,414 €3,615 +€1,201 +49.8%
Total equity and liabilities 10/49 €585,015 €590,452 +€5,436 +0.9%
Equity 10/15 €361,696 €398,417 +€36,721 +10.2%
Contributions 10/11 €20,000 €20,000 = 0.0%
Reserves 13 €336,000 €378,000 +€42,000 +12.5%
Distributable reserves 133 €336,000 €378,000 +€42,000 +12.5%
Profit (loss) carried forward 14 €5,696 €417 -€5,279 -92.7%
Amounts payable 17/49 €223,320 €192,035 -€31,285 -14.0%
Amounts payable after more than one year 17 €5,000 - -€5,000
Financial debts 170/4 €5,000 - -€5,000
Amounts payable within one year 42/48 €211,047 €185,284 -€25,763 -12.2%
Current portion of amounts payable after more than one year 42 €25,000 €5,000 -€20,000 -80.0%
Trade debts 44 €58,299 €55,112 -€3,188 -5.5%
Suppliers 440/4 €58,299 €55,112 -€3,188 -5.5%
Taxes, remuneration and social security 45 €31,030 €23,005 -€8,024 -25.9%
Taxes 450/3 €25,703 €17,537 -€8,166 -31.8%
Remuneration and social security 454/9 €5,327 €5,469 +€142 +2.7%
Other amounts payable 47/48 €96,719 €102,167 +€5,448 +5.6%
Accrued charges and deferred income 492/3 €7,272 €6,751 -€521 -7.2%
Remuneration, social security and pensions 62 €26,444 €27,716 +€1,272 +4.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €11,530 €8,695 -€2,835 -24.6%
Other operating charges 640/8 €258 €295 +€37 +14.2%
Gross operating margin 9900 €157,592 €164,872 +€7,280 +4.6%
Operating profit (loss) 9901 €119,359 €128,166 +€8,807 +7.4%
Financial income 75/76B €84 €3 -€81 -96.6%
Recurring financial income 75 €84 €3 -€81 -96.6%
Financial charges 65/66B €7,740 €7,228 -€512 -6.6%
Recurring financial charges 65 €7,740 €7,228 -€512 -6.6%
Profit (loss) for the period before taxes 9903 €111,703 €120,941 +€9,237 +8.3%
Income taxes 67/77 €31,661 €34,554 +€2,893 +9.1%
Profit (loss) for the period 9904 €80,043 €86,387 +€6,344 +7.9%
Profit (loss) for the period to be appropriated 9905 €80,043 €86,387 +€6,344 +7.9%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.